Next Article in Journal
Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling
Next Article in Special Issue
Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A 13C Stable Isotope-Resolved Metabolomic Study
Previous Article in Journal
Microbubbles-Assisted Ultrasound Triggers the Release of Extracellular Vesicles
Previous Article in Special Issue
The Impact of Melatonin on Colon Cancer Cells’ Resistance to Doxorubicin in an in Vitro Study
Open AccessArticle

Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril

Institute of Pathophysiology, Faculty of Medicine, Comenius University, Sasinkova 4, 81108 Bratislava, Slovakia
3rd Clinic of Internal Medicine, Faculty of Medicine, Comenius University, 83305 Bratislava, Slovakia
Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, 84505 Bratislava, Slovakia
Institute of Normal and Pathological Physiology, Slovak Academy of Sciences, 81371 Bratislava, Slovakia
Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, 81108 Bratislava, Slovakia
Department of Physiology, Faculty of Medicine, Charles University, 50003 Hradec Kralove, Czech Republic
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2017, 18(8), 1612;
Received: 26 May 2017 / Revised: 10 July 2017 / Accepted: 13 July 2017 / Published: 25 July 2017
(This article belongs to the Special Issue Melatonin and Its Analogues: Experimental and Clinical Aspects)
Lactacystin is a proteasome inhibitor that interferes with several factors involved in heart remodelling. The aim of this study was to investigate whether the chronic administration of lactacystin induces hypertension and heart remodelling and whether these changes can be modified by captopril or melatonin. In addition, the lactacystin-model was compared with NG-nitro-l-arginine-methyl ester (L-NAME)- and continuous light-induced hypertension. Six groups of three-month-old male Wistar rats (11 per group) were treated for six weeks as follows: control (vehicle), L-NAME (40 mg/kg/day), continuous light (24 h/day), lactacystin (5 mg/kg/day) alone, and lactacystin with captopril (100 mg/kg/day), or melatonin (10 mg/kg/day). Lactacystin treatment increased systolic blood pressure (SBP) and induced fibrosis of the left ventricle (LV), as observed in L-NAME-hypertension and continuous light-hypertension. LV weight and the cross-sectional area of the aorta were increased only in L-NAME-induced hypertension. The level of oxidative load was preserved or reduced in all three models of hypertension. Nitric oxide synthase (NOS) activity in the LV and kidney was unchanged in the lactacystin group. Nuclear factor-kappa B (NF-κB) protein expression in the LV was increased in all treated groups in the cytoplasm, however, in neither group in the nucleus. Although melatonin had no effect on SBP, only this indolamine (but not captopril) reduced the concentration of insoluble and total collagen in the LV and stimulated the NO-pathway in the lactacystin group. We conclude that chronic administration of lactacystin represents a novel model of hypertension with collagenous rebuilding of the LV, convenient for testing antihypertensive drugs or agents exerting a cardiovascular benefit beyond blood pressure reduction. View Full-Text
Keywords: lactacystin; hypertension; fibrosis; captopril; melatonin; remodelling lactacystin; hypertension; fibrosis; captopril; melatonin; remodelling
Show Figures

Graphical abstract

MDPI and ACS Style

Simko, F.; Pechanova, O.; Repova, K.; Aziriova, S.; Krajcirovicova, K.; Celec, P.; Tothova, L.; Vrankova, S.; Balazova, L.; Zorad, S.; Adamcova, M. Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril. Int. J. Mol. Sci. 2017, 18, 1612.

AMA Style

Simko F, Pechanova O, Repova K, Aziriova S, Krajcirovicova K, Celec P, Tothova L, Vrankova S, Balazova L, Zorad S, Adamcova M. Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril. International Journal of Molecular Sciences. 2017; 18(8):1612.

Chicago/Turabian Style

Simko, Fedor; Pechanova, Olga; Repova, Kristina; Aziriova, Silvia; Krajcirovicova, Kristina; Celec, Peter; Tothova, Lubomira; Vrankova, Stanislava; Balazova, Lucia; Zorad, Stefan; Adamcova, Michaela. 2017. "Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril" Int. J. Mol. Sci. 18, no. 8: 1612.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop